0

RespireRx Pharmaceuticals Inc (RSPI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Publisher Name :
Date: 18-May-2017
No. of pages: 34

Summary

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., is a pharmaceutical company with the focus on the discovery, development and commercialization of innovative products for the treatment of respiratory disorders such as brain-controlled breathing disorders, respiratory depression, sleep apnea and drug induced respiratory depression. It has two drug platforms, each with a clinical stage compound directed at breathing disorders. RespireRx’s respiratory disease product pipeline includes Dronabinol (D9-THC, D9-tetrahydrocannabinol); CX1739, a Phase II oral drug; and CX1942- an intravenous drug. Pier Pharmaceuticals, Inc. is the wholly owned subsidiary of the company. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc (RSPI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
– The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
– The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
– Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
– Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
– Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of content
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Cortex Pharma Reacquires AMPAKINE Compounds From Biovail 10
Venture Financing 11
RespireRx Pharma Raises Funds through in Venture Financing 11
RespireRx Pharma Raises USD0.1 Million in Financing 11
Partnerships 12
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 12
Licensing Agreements 13
Cortex Pharma Enters into Licensing Agreement with University of Illinois 13
Samyang Optics Enters into Licensing Agreement with Cortex Pharma 14
Equity Offering 14
Cortex Pharma Raises USD0.7 Million in First Tranche of Private Placement of Units 14
Cortex Pharma Completes Private Placement Of Common Stock For US$0.5 Million 15
Asset Transactions 16
Les Laboratoires Servier Acquires Rights Of CX1632 From Cortex Pharma Through Exercise Of Option 16
Acquisition 18
Cortex Pharma Acquires Pier Pharma, Sleep Apnea Drug Development Company 18
RespireRx Pharmaceuticals Inc - Key Competitors 20
Key Employees 21
Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 15, 2016: RespireRx Pharmaceuticals Files September 30, 2016 Quarterly Report on Form 10-Q 23
Aug 15, 2016: RespireRx Pharmaceuticals Files June 30, 2016 Quarterly Report on Form 10-Q 25
May 17, 2016: RespireRx Pharmaceuticals Files March 31, 2016 Quarterly Report on Form 10-Q 28
Mar 29, 2016: RespireRx Pharmaceuticals Files December 31, 2015 Annual Report on Form 10-K 31
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RespireRx Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cortex Pharma Reacquires AMPAKINE Compounds From Biovail 10
RespireRx Pharma Raises Funds through in Venture Financing 11
RespireRx Pharma Raises USD0.1 Million in Financing 11
RespireRx Pharma Enters into Research Agreement with National Institute of Drug Abuse 12
Cortex Pharma Enters into Licensing Agreement with University of Illinois 13
Samyang Optics Enters into Licensing Agreement with Cortex Pharma 14
Cortex Pharma Raises USD0.7 Million in First Tranche of Private Placement of Units 14
Cortex Pharma Completes Private Placement Of Common Stock For US$0.5 Million 15
Les Laboratoires Servier Acquires Rights Of CX1632 From Cortex Pharma Through Exercise Of Option 16
Cortex Pharma Acquires Pier Pharma, Sleep Apnea Drug Development Company 18
RespireRx Pharmaceuticals Inc, Key Competitors 20
RespireRx Pharmaceuticals Inc, Key Employees 21
RespireRx Pharmaceuticals Inc, Subsidiaries 22

List of Figures
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2020 RnR Company Profiles. All rights reserved.